Results 361 to 370 of about 1,173,658 (399)
Some of the next articles are maybe not open access.
Immunogenetics of hepatitis C virus
Journal of Viral Hepatitis, 2000Hepatitis C is a complex disease and a significant public health problem. The long‐term outcome of HCV infection is difficult to predict, as the virus may be eliminated or may persist to establish a chronic infection. Further investigation is required to clarify factors that determine or influence the outcome of infection, although unique host factors ...
S, McKiernan, D, Kelleher
openaire +2 more sources
Journal of Clinical Virology, 2009
A serum sample sent to the laboratory collected on February 14 2007 from an individual attending a local drug and alcohol support clinic was tested for hepatitis C virus (HCV) antibody and was reported as positive. You note that the laboratory had received a previous sample from the same person dated July 7 2006, which had been tested by the same assay
openaire +2 more sources
A serum sample sent to the laboratory collected on February 14 2007 from an individual attending a local drug and alcohol support clinic was tested for hepatitis C virus (HCV) antibody and was reported as positive. You note that the laboratory had received a previous sample from the same person dated July 7 2006, which had been tested by the same assay
openaire +2 more sources
Seminars in Fetal and Neonatal Medicine, 2007
The prevalence of chronic hepatitis C infection in the general paediatric population varies between 0.1 and 15% around the world, with the highest numbers noted in endemic areas of Africa. The risk of viral transmission from an infected mother to her child is approximately 5% and there are currently no effective preventative measures to lower it.
openaire +2 more sources
The prevalence of chronic hepatitis C infection in the general paediatric population varies between 0.1 and 15% around the world, with the highest numbers noted in endemic areas of Africa. The risk of viral transmission from an infected mother to her child is approximately 5% and there are currently no effective preventative measures to lower it.
openaire +2 more sources
Global epidemiology of hepatitis C virus infection.
Lancet. Infectious Diseases (Print), 2005C. Shepard, L. Finelli, M. Alter
semanticscholar +1 more source
Cervical cancer prevention and control in women living with human immunodeficiency virus
Ca-A Cancer Journal for Clinicians, 2021Philip E Castle, Vikrant V Sahasrabuddhe
exaly
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Binding of hepatitis C virus to CD81.
Science, 1998P. Pileri +10 more
semanticscholar +1 more source
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Nature, 2005E. Meylan +6 more
semanticscholar +1 more source
Replication of hepatitis C virus
Microbiology, 2000R, Bartenschlager, V, Lohmann
openaire +2 more sources